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 The 47-kD heat shock protein 47 (HSP47), a major 
collagen-binding stress protein, is thought to play an impor-
tant role in fibrotic diseases. To investigate the role of 
HSP47 in the fibrotic process of crescent formation in renal 
glomeruli, involvement of HSP47 was examined in both 
human and experimental crescentic glomerulonephritis (GN). 
Renal biopsy sections of 15 cases of crescentic GN and 5 
cases of minimal change nephrotic syndrome were examined 
for the expression of HSP47. Experimental crescentic GN 
was induced by anti-glomerular basement membrane anti-
body in rats. HSP47 expression was examined in crescents 
at various stages of formation (days 7, 14, 21, 28 and 42). 
In human renal biopsy sections, increased expression of 
HSP47 was noted in the cellular stage of crescent forma-
tion. Double immunostaining demonstrated that the major-
ity　 of　 α-smooth　 muscle　 actin-positive　 cells　 in　 the　 crescent
expressed HSP47. However, its expression was less in fi-
brous crescents, which were predominantly composed of 
type III collagen. In the rat model of crescent GN, increased 
expression of HSP47, both at mRNA and protein levels, was 
noted in the early stages of cellular crescents. However, its 
expression was decreased in the late stages of fibrous cres-
cents. Based on the collagen synthesis ability of HSP47, we 
speculate that overexpression of HSP47 in cellular crescents 
may contribute to the excessive synthesis/ assembly of 
collagens and subsequently lead to irreversible fibrous cres-
cent formation.
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Introduction
 Crescentic glomerulonephritis (GN) is a rapidly pro-
gressive renal disease, characterized histologically by 
the early appearance of cellular circumferential cres-
cents in the glomeruli, which subsequently lead to fi-
brous crescent formation. While early treatment can 
resolve certain forms of cellular crescents, their trans-
formation into fibrous crescents is an irreversible 
pathological process. Crescentic GN can be induced ex-
perimentally in laboratory animals by injection of anti-
glomerular basement membrane (GBM) antibody. The 
renal tissues of these animals exhibit various stages of 
crescent formation with disease progression, resulting 
in prominent glomerular and interstitial fibrosis, simi-
lar to that seen in human crescentic GN. It has been 
widely noted that increased deposition of extracellular 
matrix (ECM), especially collagens, may contribute to 
fibrous crescent formation, but the factors that regu-
late increased synthesis of collagens during this proc-
ess have not yet been identified (1, 2). 
 HSP47, a collagen-specific stress protein, is involved in 
the processing and/or assembly of procollagens (3, 4). 
Both human and experimental studies have shown 
that the expression of HSP47 is upregulated in the 
fibrotic process and correlates with excessive accumu-
lation of collagens (5-10). Whether HSP47 plays any 
role in crescent formation is not yet known, but inves-
tigation of the involvement of HSP47 in the develop-
ment of fibrous crescents is potentially important since 
such involvement implies the possible manipulation of 
fibrotic crescent formation (11, 12). The present study 
was undertaken to evaluate the role of HSP47 in the 
development of crescent formation in both human and 
experimentally-induced rat crescentic GN.
Materials and Methods
Tissue specimens 
 Human renal biopsy sections from 15 cases with 
histologically diagnosed crescentic GN were selected 
for this study. As control, we selected tissue sections 
from 5 cases of minimal change nephrotic syndrome 
(Table 1). The study protocol was approved by the 
Human Ethics Review Committee of Nagasaki 
University School of Medicine.
Table 1: Clinical and histopathological findings in human 
crescentic glomerulonephritis.
Case no Age/sex Clinical diagnosis Serum creatinine (mg/dl) Histopathological 
A) Crescentic glomerulonephritis 
 1. 63 M IgAN 3.8 Crescentic GN 
2. 76 F RPGN 3.4 Crescentic GN 
3. 48 M RPGN 3.1 Crescentic GN 
4. 62 M CGN, Hypertension 1.1 Crescentic GN 
5. 70 M NS, Lung ca, Liver dysf. 1.0 Crescentic GN 
6. 53 F NS 1.0 Crescentic GN 
7. 64 M CGN 1.4 Crescentic GN 
8. 84 M PN 1.5 Crescentic, necrotizing GN 
9. 62 F RPGN 4.6 Advanced crescentic GN 
10. 57 M ARF, ANCA related GN 7.9 Advanced crescentic GN 
11. 76 M Goodpasture's syndrome 11.2 Crescentic GN 
12. 62 F RPGN 11.7 Crescentic, necrotizing GN 
13. 36F AGN, suspected 1.5 Crescentic GN 
14. 76 F CGN, ANCA related GN 1.3 Crescentic GN 
15. 71 F RPGN 8.1 Crescentic GN 
B) Control : cases of MCNS 
 1. 20 F NS 0.5 MCNS 
 2. 31 M NS 0.6 MCNS 
3. 16 F NS 0.8 MCNS 
 4. 21 M NS 0.9 MCNS 
 5. 49 F NS, DM 0.6 MCNS
IgAN : IgA nephritis, GN : glomerulonephritis, RPGN : Rapidly progressive glomerulonephritis, 
CGN : Chronic glomerulonephritis, NS : Nephrotic syndrome, ca : carcinoma, dysf. : dysfunction, 
PN : Polyarteritis nodosa, ARF : Acute renal failure, AGN : Acute glomerulonephritis, DM : Diabetes 
mellitus, MCNS : Minimal change nephrotic syndrome
Preparation of rat model of crescentic glomerulonephritis 
 Five-week old male Sprague Dawly rats (n=20) 
were primed with subcutaneous injection of rabbit IgG in 
Complete Freund's Adjuvant (5 mg/kg, Sigma Chemical 
Co., St. Louis, MO), five days prior to the induction of 
accelerated anti-GBM nephritis (13). Induction of 
crescentic GN was achieved by intravenous admini-
stration of 12.5 mg IgG/ kg rabbit anti-rat GBM anti-
body (Otsuka, Japan). Rats were sacrificed on day 7, 
14, 21, 28 or 42 after induction of nephritis. Control 
rats (n=5) were preimmunized, but GN was not in-
duced. Both kidneys were dissected out, fixed, paraffin 
embedded, sectioned and stained with hematoxylin 
eosin (HE), periodic acid-Schiff (PAS), periodic acid-
methenamine silver (PAM) and Mallory azan. The ex-
perimental protocol was approved by the Ethics
Review Committee for Animal Experimentation of 
Nagasaki University School of Medicine.
Immunohistochemistry 
 Immunohistochemistry was performed as described 
earlier (14, 15). Briefly, paraffin embedded tissue sec-
tions were deparaffinized, rehydrated in graded alco-
hol, treated with 0.3% hydrogen peroxide/methanol to 
block endogenous peroxidase activity. After mild treat-
ment with trypsin (T-8253, Sigma, 10 mg/ 100 ml of 
0.01 M PBS, 3 min), tissue sections were incubated 
overnight with an antibody against HSP47 (StressGen 
Biotechnologies Corp., Canada). Sections were then 
processed with Histofine SAB kit (Nichirei, Japan) for 
staining by the immunoperoxidase method and the 
Histostain-SAP Kit (Zymed Laboratories Inc., San 
Francisco, CA) for staining by the alkaline phosphatase 
method. In addition to HSP47, both human and rat kid-
ney sections were stained for collagens (type III and 
IV) and a -smooth muscle actin (a -SMA). Normal 
mouse IgG and rabbit IgG were used as negative con-
trol. The source of antibodies used in the present ex-
periments has been reported previously (5, 6, 14, 15).
Table 2: Immunohistochemical expression of HSP47 in cases 
of human crescentic GN
case no. Glomeruli Interstitium Tubules 
     Tutfs crescent 
               Cellular Fibrocellular Fibrous 
(Crescentic glomerulonephritis) 
 1 + +++ + - + ++.+++ 
 2 + +++ + - + ++ 
 3 + +++ ++ - ++ ++ 
4 +-++ +++ NC NC ++ + 
 5 + +++ NC - + ++ 
 6 +-++ +++ ++ - ++ ++ 
 7 + +++ ++ - + ++ 
 8 +-++ +++ + NC +-++ ± 
 9 + +++ ++ - ++ + 
10 +-+ +++ + - ++ ++ 
11 + +++ ++ - + ++.+++ 
12 ± ++ ++ - + ++ 
13 ++ +++ ++ NC +++ + 
14 + +++ + - + ++.-+++ 
15 + NC + - + + 
(Control : cases of MCNS) 
 1 ± NC ± ± 
2 ± NC ± ± 
3 ± NC ± ± 
4 ± NC ± ± 
 5 + NC + +
No crescent : NC No expression : - Faintly positive : ± 
Mild expression : + Moderate expression : ++ Severe expression : +++
Double immunostaining 
 Double immunostaining was carried out to detect 
HSP47/collagen type III, HSP47/collagen type IV, HS
P47/ a-SMA in the same renal section as described 
previously (14, 15). Briefly, HSP47 was stained first 
by streptavidin-alkaline phosphatase method and de-
veloped by 5-bromo-4-chlor-3-indolyl-phosphate (BCIP) 
/ nitroblue tetrazolium (NBT) which produced black pur-
ple colored signal. Then the slides were counterstained 
with either collagens (type III and IV) or a-SMA by 
streptavidin-biotin peroxidase method and developed 
by aminoethylcarbazole (AEC) / HZO2, which produced 
intense red colored stain.
R T-PCR 
  RT-PCR was performed using homogenized renal 
cortical tissue (homogenizer: Polytron, PT 1200, 
Switzerland). Total RNA was extracted by phenol and 
guanidine isothiocyanate method using TRIzoL LS rea-
gent (Gibco BRL, Long Island, NY). cDNA was pre-
pared using the ssDNA synthesis kit (Superscript Pre-
amplification kit, Gibco BRL) as instructed by the 
manufacturer. Briefly, 4 u m of total RNA was incu-
bated with 50 ng of random hexamer at 701C for 10 
minutes then rapidly chilled at 4 °C and kept at least 
for 1 minute. In the next step, deoxynucleoside 
triphosphate (dNTP) mix, 10 mM dithiothreitol (dTT), 
and 10 mM MgC12 were added and further incubated 
for 5 minutes at 25C. °Then, Superscript II reverse 
transcriptase (RT) was added from the kit, and incu-
bated at 42°C for 50 minutes. The reaction was termi-
nated by heating the mixture at 70°C for 15 minutes. 
To remove residual RNA, Escherichia coli RNaseH was 
mixed gently with the product and kept at 37°C for 20 
minutes. Thus, the prepared cDNA was stored in -20 
°C u ntil PCR amplification. Amplification of target 
DNA of HSP47 was carried out with forward primer 
(5'-ACCACAGGATGGTGGACAACCGT-3') and reverse 
primer (5'-ATCTCGCATCTTGTCTCCCTTGGG-3') in-
corporation using the Gene Amp, PCR Reagent Kit 
with AmpliTaq DNA polymerase (Perkin-Elmer, 
Norwalk, CT, Roche). Thirty cycles of denaturation at 
94°C for 1 minute, annealing at 55°C for 1 minute and 
extension at 72C for 2 minutes were arranged in a 
thermocycler (PC701, ASTEC Co., Japan) and then 
PCR products were kept at VC. DNA electrophoresis 
of PCR products was performed through 2 % agarose 
gel with ethidium bromide. 100 by DNA ladder was 
used as a molecular marker to interpret the location of 
amplified DNA. PCR products were visualized by ultra-
violet exposure and analyzed by densitometry with 
positive control of (3-actin.
Results
Human renal biopsies 
 The clinical profiles of patients from whom renal bi-
opsies were obtained are summarized in Table 1. All 
renal biopsies of crescentic GN showed various stages of 
circumferential crescents (cellular, fibrocellular and fibr-
ous). Immunohistochemically, overexpression of HSP47 
was identified in cellular (Fig. 1A) and fibrocellular 
crescents, but low expression was noted in fibrous 
crescents (Fig. 1B). Using double immunostaining, the 
major source of HSP47 was found to be a -SMA-
immunopositive cells in the crescents (Fig. IC). In addi-
tion to the crescents, intraglomerular cells and 
tubulointerstitial cells were also found to express 
HSP47 in the sclerotic glomeruli and interstitial 
fibrotic areas, respectively. The expression of HSP47 in 
different components of the studied cases is shown in 
Table 2. Increased deposition of type III collagen was 
also seen in fibrous crescents (Fig. ID).
Morphological changes in experimental renal tissues 
 The renal tissue at day 7 after injection of rabbit 
anti-rat GBM antibody showed no apparent 
histopathological lesions, except for focal inflammatory 
cell infiltration in a few glomerular tufts. However, 
marked histopathological changes occurred at day 14, 
characterized by increased glomerular size, mild 
hypercellularity of the glomerular tufts, and exudative 
materials in Bowman's space. The glomerular lesions 
were subsequently followed by the appearance on day 21 
of focal cellular and then circumferential crescents of 
cellular and fibrocellular variants (Fig. 2A and B). 
Progressive development of glomerular sclerosis with 
interstitial fibrosis was observed during the experi-
mental period after day 21. The majority of crescents 
became fibrotic at day 42 (Fig. 2C). On the other 
hand, no morphological changes were noted in the 
control rat kidneys throughout the entire experimental 
period (Fig. 2D).
Immunohistochemical analysis of HSP47 in rat kidney 
sections 
 A few intraglomerular cells and interstitial cells 
showed weak expression of HSP47 in control renal tis-
sues (Fig. 3A). In experimental rats, increased expres-
sion of HSP47 was noted in early cellular and 
fibrocellular crescents (Fig. 3B). In addition, cells of 
the contracted glomerular tufts showed strong expres-
sion of HSP47. A gradual increase in the expression of 
HSP47 was noted in the early stages while its
expression decreased in the late stages of fibrotic le-
sions (Fig. 3C).
Immunohistochemical analysis of collagens in rat kidney 
sections 
 Mild interstitial deposition of type III collagen was 
noted in control renal sections (Fig. 4A), while mark-
edly increased expression was noted in and around the 
crescents, sclerotic glomeruli and widened interstitium 
(Fig. 4B). As for type IV collagen, a weak expression 
was noted in the GBM, tubular basement membrane 
and mesangial matrix of control renal sections (Fig. 
4C). Increased expression was noted in the widened 
interstitium, thickened tubular basement membrane 
and sclerotic glomeruli (Fig. 4D). Increased deposition 
of collagens was noted in all stages of experimental 
nephritis. Double staining showed that overexpression 
of HSP47 correlated with increased deposition of 
collagens (Fig. 4E and F). However, the expression of 
HSP47 in crescents was noted only in cellular and 
fibrocellular components.
Identification of HSP47 expressing cells in rat kidney 
sections 
  Compared to control kidney sections, numerous a -
SMA-positive cells were noted in cellular and 
fibrocellular crescents, glomerular tufts and in the 
interstitium in GN kidneys (Fig. 5B). Double 
immunostaining revealed that a -SMA-positive cells 
frequently coexpressed HSP47 in glomeruli (Fig. 5C) 
and interstitium (Fig. 5D).
RT-PCR analysis of mRNA for HSP47 in rat kidney sec-
tions 
 Compared to the control kidney, relatively stronger 
bands were seen in the kidneys in early crescentic GN 
in and around 600 by (arrow), indicating increased ex-
pression of HSP47 mRNA in GN kidney until 28 days 
(Fig. 6). The HSP47 band decreased in intensity at 
day 42. RT-PCR products of ~-actin of the correspond-
ing lanes are shown at the bottom (Fig. 6).
Discussion
 Crescentic GN is characterized by segmental or 
circumferential crescents associated with a variable de-
gree of destruction of capillary tufts. These pathologi-
cal structures either subsequently show a complete 
resolution, though rare, or persist and undergo trans-
formation from a cellular to fibrocellular form and
ultimately change to complete fibrous crescents (1, 2). 
In general, the presence of fibrous crescents represents 
irreversible damage, which leads to a permanent im-
pairment of renal functions. When the crescents are 
circumferential, the glomerular tufts usually show col-
lapse and gradually change to global sclerosis. Since 
advanced stage of fibrous crescent formation is closely 
related to subsequent glomerular damage, manipula-
tion of crescents in the early stages might modulate 
glomerular damage. Although increased deposition of 
ECM including collagens is mainly responsible for the 
advanced stage of fibrous crescent formation, factors 
that regulate increased synthesis of collagens are not 
yet clear. In this study, the possible role(s) of HSP47 
in fibrous crescent formation was investigated in 
human and experimental crescentic GN. The major 
finding of our study was the enhanced expression of 
HSP47 in early cellular crescents, which was followed 
by collagen-rich fibrous crescent formation. 
 Although the exact relationship between increased 
expression of HSP47 in the cellular crescent and in-
creased deposition of collagens in the late stage of fi-
brous crescent is difficult to verify based on our re-
sults, previous studies have demonstrated that HSP47 
is closely related to collagen synthesis in other sclero 
tic/fibrotic processes in various organs in both human 
and experimental animals (5, 6, 14-17). Furthermore, 
in vitro experiments have clearly shown the impor-
tance of HSP47 during collagen assembly/synthesis (3, 
4). Thus, based on the results of these early studies 
and the present findings, we speculate that increased 
expression of HSP47 in early crescents might be asso-
ciated with increased synthesis of collagens with sub-
sequent fibrous crescent formation in the late stage. 
Consistent with earlier observations (5, 7, 8, 10-12, 14, 
16, 17), apart from crescents, increased expression of 
HSP47 was also observed in sclerotic glomeruli and 
around the fibrotic interstitium in both human and ex-
perimental crescentic GN, suggesting the possible role 
of HSP47 in sclerotic/ fibrotic process. These results 
imply that suppression of HSP47 expression might be 
of therapeutic value as it might potentially modulate 
the process of sclerosis/ fibrosis in crescentic GN (11, 
12). 
 In conclusion, we demonstrated in the present study 
increased expression of HSP47 in the early cellular 
crescents, which subsequently exhibited increased 
deposition of collagens in fibrous crescents. Based on 
the collagen synthesizing ability of HSP47, we specu-
late that increased synthesis of collagen might subse-
quently lead to irreversible fibrous crescent formation. 
In order to define that exact relationship between 
HSP47 and fibrous crescent formation, additional
Fig. 1: Immunohistochemical expression of HSP47 in cases of human crescentic GN with cellular crescent (A) and fibrous cres-
cent (B). Double immunostaining of HSP47 (black purple) and a-smooth muscle actin (red) showing colocalization in cells of 
cellular/fibrocellular crescents and interstitial cells (C). Expression of type III collagen in fibrous crescent (D). Arrows indicate 
crescents. Original magnification, x100.
Fig. 2: Morphological changes in experimental GN. Cellular crescent at day 21 (A), fibrocellular crescent at day 28 (B), fibrous 
crescent at day 42 (C) and control (D). Arrows indicate crescents. (PAS stain, original magnification, x100).
Fig. 3: Immunohistochemical expression of HSP47 in experimental GN. Control (A), fibrocellular crescent (B) and fibrous cres-
cent (C). Arrows indicate crescents. Original magnification, x100.
Fig. 4: Expression of collagens and HSP47 in experimental GN. Type III collagen in control (A) and experimental GN (B), 
Type IV collagen in control (C) and experimental GN (D). .
Fig. 4: Double immunostaining of HSP47 (black purple) and type III collagen (red) (E) and HSP47 and type IV collagen (red) 
(F). Collagens III and IV are abundant in fibrous (single arrow) and fibrocellular (double arrow) crescents, but the expression 
of HSP47 is only noted in fibrocellular crescents. Original magnification, x100.
Fig. 5: Immunohistochemical expression of a-smooth muscle actin in control (A) and crescentic GN (B). Double immunostaining of 
HSP47 (black purple) and a-smooth muscle actin (red) in a glomerulus with cellular crescent (C) and interstitium (D) of GN 
kidney. Original magnification, x100.
Fig. 6: Amplification of mRNA of HSP47 by RT-PCR shows 
prominent bands during 7th to 28th day of induction of 
glomerulonephritis. Lanes indicate control, 7th, 14th, 21st, 
28th and 42nd days. The corresponding /3-actin expression 
is shown at the bottom.
studies are needed in which the expression of HSP47 
is modulated in experimental crescentic GN. Such 
studies would enhance our understanding of the role 
of HSP47 in humans particularly in the regulation of 
the fibrotic process in crescentic GN.
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